I believe those people who have already analyzed the PharmAthene (NYSEMKT:PIP) vs. SIGA (NASDAQ:SIGA) legal case are trying to over complicate the Delaware Supreme Court's (NYSE:SC) May 24, 2013 opinion. Many people still believe the original equitable damages award granted by Judge Parsons is still an option since the Supreme Court seemed to be throwing out Judge Parsons' damage award only as it related to reversing promissory estoppel. The below excerpt starting at the bottom of page 37 and continuing on page 38 of the above Supreme Court opinion seemed to be interpreted by a lot of people as to the possibility of an equitable damage award still being an option for Judge Parsons....
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|